Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
137.00
-5.00 (-3.52%)
Sep 24, 2026, 1:30 PM CST

Gongwin Biopharm Holdings Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
16,59310,55814,36920,91136,13231,104
Market Cap Growth
35.32%-26.53%-31.28%-42.13%16.16%17.15%
Enterprise Value
15,2329,02112,19420,03635,49830,383
Last Close Price
137.0086.10113.50184.50319.50279.64

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
392.99289.68448.481105.5031611.2427212.59
PB Ratio
7.134.194.6415.9426.3131.50
P/TBV Ratio
7.144.174.6315.9025.9632.04

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-247.53380.581059.2631056.7426581.68

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.060.050.040.060.100.12
Net Debt / Equity Ratio
-0.58-0.61-0.67-0.66-0.70-0.72
Net Debt / EBITDA Ratio
5.867.7413.546.923.826.30
Net Debt / FCF Ratio
6.8711.177.107.754.023.26
Asset Turnover
0.020.010.010.010.000.00
Inventory Turnover
3.844.633.011.27--
Quick Ratio
7.299.3712.277.585.805.34
Current Ratio
8.1910.3613.368.866.995.95
Return on Equity (ROE)
-7.36%-4.31%-4.17%-7.54%-24.75%-12.34%
Return on Assets (ROA)
-5.65%-4.19%-4.14%-5.31%-11.66%-6.36%
Return on Capital Employed (ROCE)
-9.90%-7.90%-5.10%-9.60%-18.20%-11.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.99%-1.08%-0.57%-0.44%-0.81%-0.39%
FCF Yield
-1.19%-1.30%-2.04%-0.53%-0.66%-0.70%
Buyback Yield / Dilution
2.82%-2.19%-6.64%-1.92%-1.44%-4.87%